Losses are forecast to balloon 33% to US$1.27 per share. Before this earnings announcement, the analysts had been modelling revenues of US$30.3m and losses of US$1.27 per share in 2024. 考虑到最新业绩,涵盖Tango Therapeutics的六位分析师提供了共识估计,2024年收入为3,240万美元,这将反映出过去...
View Tango Therapeutics, Inc. TNGX stock quote prices, financial information, real-time forecasts, and company news from CNN.